Regulation of experimental autoimmune encephalomyelitis by chemokines and chemokine receptors

Immunologic Research

Volumn 25, Issue 2, 2002, Pages 167-175

  Elhofy, Adam ^a   Kennedy, Kevin J ^a   Fife, Brian T ^a   Karpus, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Autoimmune; Chemokinds; Chemokine receptors; Encephalomyelitis

Indexed keywords

CALCIUM BINDING PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASTROCYTE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; MOUSE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

ANIMALS; CHEMOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; RECEPTORS, CHEMOKINE;

EID: 0036204658     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:25:2:167     Document Type: Article

References (45)

1. The pathology of multiple sclerosis: A historical perspective
2. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases
3. Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis
4. Migration of hematogenous cells through the bloodbrain barrier and the initiation of CNS inflammation
5. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis
6. Diversity and plasticity of self recognition during the development of multiple sclerosis
7. Epidemiological evidence for multiple sclerosis as an infection
8. Infection and multiple sclerosis: A possible role for superantigen?
9. Is MS an auto-immune disease or achronic gammaherpesvirus infection
10. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA
11. A quantitative immunohistochemical comparison of actively versus adoptively induced experimental allergic encephalomyelitis in the Lewis rat
12. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin
13. Antibodies against leukocyte function-associated antigen- 1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis
14. Short term treatment with soluble neuroantigen and anti-CD1 la (LFA-1) protects rats against autoimmune encephalomyelitis - Treatment abrogates autoimmune disease but not autoimmunity
15. Partial inhibition of AT-EAE by an antibody to ICAM-1: Clinico-histological and MRI studies
16. Chemokines: A new classification system and their role in immunity
17. International union of pharmacology. XXII. Nomenclature for chemokine receptors
18. The biology of chemokines and their receptors
19. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis
20. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis
21. Chemokine expression in murine experimental allergic encephalomyelitis
22. C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system
23. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis
24. Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis
25. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis
26. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
27. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1
28. Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis
29. Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: Implications for establishment of a Th1/Th2 bias
30. Experimental autoimmune encephalomyelitis on the SJL mouse: Effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system
31. Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 protein
32. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent
33. CC Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis
34. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1
35. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein- 1alpha or its CCR5 receptor
36. Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor
37. Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1
38. A new class of membrane-bound chemokine with a CX3C motif
39. Chemokine receptor antagonism as a new therapy for multiple sclerosis
40. Chemokines in immune-mediated inflammation of the central nervous system
41. Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis
42. Kinetics and cellular origin of cytokines in the central nervous system: Insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis
43. Localization of monocyte chemoattractant peptide-1 expression on the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat
44. + T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis